These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19465102)

  • 1. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
    Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
    Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
    Liu H; Pan W; Ke P; Dong Y; Ji L
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
    Dhaliwal S; Jain S; Singh HP; Tiwary AK
    AAPS J; 2008 Jun; 10(2):322-30. PubMed ID: 18523891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and optimisation of mucoadhesive nanoparticles of acyclovir using design of experiments approach.
    Kharia AA; Singhai AK
    J Microencapsul; 2015; 32(6):521-32. PubMed ID: 26333938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK; Chavda JR
    J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of theophylline and thiamine disulfide incorporated into mucoadhesive microspheres consisting of dextran derivatives and cellulose acetate butyrate.
    Miyazaki Y; Ogihara K; Yakou S; Nagai T; Takayama K
    Biol Pharm Bull; 2003 Dec; 26(12):1744-7. PubMed ID: 14646183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin.
    Liu Z; Lu W; Qian L; Zhang X; Zeng P; Pan J
    J Control Release; 2005 Jan; 102(1):135-44. PubMed ID: 15653140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
    Patel JK; Patel MM
    Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
    de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
    J Control Release; 2001 Jul; 75(1-2):191-7. PubMed ID: 11451509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
    Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
    Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
    Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.
    Malik NS; Ahmad M; Alqahtani MS; Mahmood A; Barkat K; Khan MT; Tulain UR; Rashid A
    Drug Deliv; 2021 Dec; 28(1):1093-1108. PubMed ID: 34114907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
    Rajinikanth PS; Karunagaran LN; Balasubramaniam J; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1658-64. PubMed ID: 19043235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
    Paul S; Kumar A; Yedurkar P; Sawant K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive tablets for controlled release of acyclovir.
    Ruiz-Caro R; Gago-Guillan M; Otero-Espinar FJ; Veiga MD
    Chem Pharm Bull (Tokyo); 2012; 60(10):1249-57. PubMed ID: 22863800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of sustained release and conventional formulation of acyclovir.
    Zhang JH; Zhu JB; Chen XJ; Zhao R; Gang YY; Wu ZH; Cheng K; Xu XY
    Eur J Drug Metab Pharmacokinet; 2001; 26(3):145-8. PubMed ID: 11695713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.
    Sankar R; Jain SK
    Drug Des Devel Ther; 2013; 7():1455-69. PubMed ID: 24348022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats.
    Djekic L; Janković J; Rašković A; Primorac M
    Eur J Pharm Sci; 2018 Aug; 121():287-292. PubMed ID: 29883728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation.
    Alsarra IA; Hamed AY; Alanazi FK
    Drug Deliv; 2008 Jun; 15(5):313-21. PubMed ID: 18763162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.